Product News
- Product News2023/05/11
- Oral ingestion of senolytics restores α-Klotho in humans and mice
Any IBL product introduced in this IBL news is applicable for research use only and it cannot be used for diagnosis or medical purpose.A research group led by Dr. James L. Kirkland, Department of Internal Medicine, Division of General Medicine, Mayo Clinic, conducted 1) experiments using various primary human cells co-cultured with culture supernatants of senescent and non-senescent cells.
They conducted 2) an experiment in which senolytics was administered to aged mice, obese mice, and mice transplanted with senescent cells.
They also conducted 3) a study in which a combination of senolytics and drug was administered to patients with idiopathic pulmonary fibrosis.
In these, they assessed α-Klotho expression in cells and/or urinary α-Klotho in mice and humans.
As a result, 1) α-Klotho expression was decreased in various non-senescent cells exposed to secretome from senescent cells, and 2) in young mice transplanted with senescent cells, α-Klotho expression was decreased in the brain and in the urine.
They found that in aged mice, diet-induced obese mice, and mice transplanted with senescent cells, selective genetic and pharmacological depletion of senescent cells increased α-Klotho levels in the urine and in the kidney and brain in these mice.
And they reported 3) that administration of a combination of senolytics and drug to human patients with idiopathic pulmonary fibrosis restored urinary α-Klotho levels.
(Article)
Zhu Y et al. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans. EBioMedicine. 2022 Mar;77:103912.
(Background)
α-Klotho has been studied as an anti-aging protein that may help mitigate the deleterious changes and diseases associated with aging.
Indeed, decreased α-Klotho has been reported as a hallmark of various diseases and aging.
Previous nonclinical studies have suggested that boosting α-Klotho expression may have therapeutic potentials, but no practical means of increasing α-Klotho levels were known.
In this report, it is noteworthy that orally ingestible senolytics improved aging and restored α-Klotho levels in mice and humans.
In this paper, our ELISA kits below are used to measure α-Klotho in mouse and human urine.
#27601 Mouse soluble α-Klotho Assay Kit - IBL
#27998 Human soluble α-Klotho Assay Kit - IBL
We hope that we can support your research.
Please feel free to contact us.
Sales Department
Antibody related Business Division
Immuno-Biological Laboratories Co., Ltd.
Email: do-ibl@ibl-japan.co.jp

IBL-Japan (Specific Antibody Development) 30sec video
IBL-Japan (Specific Antibody Development) 2min video
LipoSEARCH® - Lipoprotein Analyzing Systems (Patented GP-HPLC Systems) 30sec video
